James Shin
Stock Analyst at Deutsche Bank
(2.77)
# 1,779
Out of 5,124 analysts
23
Total ratings
60%
Success rate
22.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $108.87 | +1.96% | 3 | Nov 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $1,064.04 | -15.42% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $9.60 | +4.17% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $121.36 | -1.12% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $330.17 | -7.62% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $106.66 | -43.75% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $54.42 | -17.31% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $20.98 | +185.99% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $223.93 | -33.01% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $776.54 | +3.02% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.00 | +400.00% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $11.52 | +941.67% | 1 | Nov 9, 2023 |
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $108.87
Upside: +1.96%
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $1,064.04
Upside: -15.42%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $9.60
Upside: +4.17%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $121.36
Upside: -1.12%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $330.17
Upside: -7.62%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $106.66
Upside: -43.75%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $54.42
Upside: -17.31%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $20.98
Upside: +185.99%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $223.93
Upside: -33.01%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $776.54
Upside: +3.02%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $2.00
Upside: +400.00%
Nov 9, 2023
Initiates: Buy
Price Target: $120
Current: $11.52
Upside: +941.67%